跳至主要内容
临床试验/JPRN-UMIN000001071
JPRN-UMIN000001071已完成未知

Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD) - Ezetimibe therapy for Non-alcoholic fatty liver disease (NAFLD)

Osaka City University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2011年6月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. past history of hypersensitivity to Ezetimibe 2. clinical sighs of severe liver injury such as acute hepatitis, acute exacerbation of chronic hepatitis, cirrhosis in Child B or C, hepatocellular carcinoma, and jaundice in combination with Statin. 3. women who are or possibly pregnant 4. past history of atherosclerotic disease(myocardial infarction , angina pectoris, cerebral stroke, and so on). 5. secondry hyperlipidemia or drug induced hyperlipidemia

研究者

发起方
Osaka City University Graduate School of Medicine

相似试验